Within the GCH1/BH4 system, dihydrofolate reductase (DHFR) further utilizes NADPH to facilitate BH4 production [5] ( Fig
This prolonged, supraphysiological stimulation results in greater glucose-lowering effects, more pronounced appetite suppression, and clinically significant weight loss that varies by medication and dose: approximately 5-8% with liraglutide 3 mg, 10-15% with semaglutide 2.4 mg, and 15-22% with tirzepatide at higher doses
Pharmaceutical companies have a responsibility to thoroughly test their products and provide adequate warnings about potential side effects
Enteric glia: diversity or plasticity
The pill is at a preclinical stage of testing, meaning it has not yet entered human trials
But healthcare behaves more like a utilitysubject to policy swings and payer power